Sintx Technologies, Inc. (NASDAQ:SINT – Get Free Report) was the recipient of a significant decrease in short interest in the month of September. As of September 15th, there was short interest totaling 96,852 shares, a decrease of 42.2% from the August 31st total of 167,475 shares. Based on an average daily trading volume, of 23,670 shares, the days-to-cover ratio is currently 4.1 days. Currently, 2.3% of the company’s shares are short sold.
Analysts Set New Price Targets
Several research firms have recently issued reports on SINT. Maxim Group restated a “buy” rating and set a $6.00 target price on shares of Sintx Technologies in a research report on Thursday, June 4th. Weiss Ratings reissued a “sell (e+)” rating on shares of Sintx Technologies in a research note on Friday, July 17th. Finally, Ascendiant Capital Markets boosted their price objective on shares of Sintx Technologies from $12.00 to $12.50 and gave the company a “buy” rating in a report on Thursday. Three equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to MarketBeat, Sintx Technologies has a consensus rating of “Moderate Buy” and an average target price of $9.50.
Check Out Our Latest Report on SINT
Sintx Technologies Stock Up 0.4%
Sintx Technologies (NASDAQ:SINT – Get Free Report) last posted its quarterly earnings data on Tuesday, August 11th. The company reported ($0.75) EPS for the quarter, missing the consensus estimate of ($0.73) by ($0.02). The company had revenue of $0.45 million during the quarter, compared to the consensus estimate of $0.46 million. Sintx Technologies had a negative net margin of 848.20% and a negative return on equity of 354.44%. As a group, equities analysts predict that Sintx Technologies will post -1.67 earnings per share for the current fiscal year.
Sintx Technologies Company Profile
SINTX Technologies, Inc is an advanced materials company that develops and manufactures silicon nitride-based ceramics. Its technology is designed to provide properties such as high strength, wear resistance, biocompatibility and antimicrobial performance, supporting applications in healthcare and other demanding industries.
The company’s medical activities have focused on ceramic components and implantable products for orthopedic and spinal procedures, including technologies used in spinal fusion and other reconstructive applications.
See Also
- Five stocks we like better than Sintx Technologies
- Corning and AT&T’s $3 Billion Fiber Deal Reveals Where AI Spending Goes Next
- Target’s Holiday Blitz: Slashing Prices to Capture Market Share
- NIO Inc.’s Geely Deal Is Really a Bet on Battery-Swap Network Utilization
- Remitly’s September Pullback Tests a Still-Strong Growth Story
Receive News & Ratings for Sintx Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sintx Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
